-
1
-
-
84930188532
-
Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma
-
Jones C, Baker SJ. Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma. Nat Rev Cancer. 2014;14(10):651–661.
-
(2014)
Nat Rev Cancer
, vol.14
, Issue.10
, pp. 651-661
-
-
Jones, C.1
Baker, S.J.2
-
2
-
-
84903198110
-
A neurocentric perspective on glioma invasion
-
Cuddapah VA, Robel S, Watkins S, Sontheimer H. A neurocentric perspective on glioma invasion. Nat Rev Neurosci. 2014;15(7):455–465.
-
(2014)
Nat Rev Neurosci
, vol.15
, Issue.7
, pp. 455-465
-
-
Cuddapah, V.A.1
Robel, S.2
Watkins, S.3
Sontheimer, H.4
-
3
-
-
70449517400
-
Antiangiogenic therapies for high-grade glioma
-
Norden AD, Drappatz J, Wen PY. Antiangiogenic therapies for high-grade glioma. Nat Rev Neurol. 2009;5(11):610–620.
-
(2009)
Nat Rev Neurol
, vol.5
, Issue.11
, pp. 610-620
-
-
Norden, A.D.1
Drappatz, J.2
Wen, P.Y.3
-
4
-
-
84858796263
-
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
-
Turcan S, Rohle D, Goenka A, et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature. 2012;483(7390):479–483.
-
(2012)
Nature
, vol.483
, Issue.7390
, pp. 479-483
-
-
Turcan, S.1
Rohle, D.2
Goenka, A.3
-
5
-
-
84955207765
-
CD133 and DNA-PK regulate MDR1 via the PI3K- or Akt-NF-κB pathway in multidrug-resistant glioblastoma cells in vitro
-
Xi G, Hayes E, Lewis R, et al. CD133 and DNA-PK regulate MDR1 via the PI3K- or Akt-NF-κB pathway in multidrug-resistant glioblastoma cells in vitro. Oncogene. 2016;35(2):241–250.
-
(2016)
Oncogene
, vol.35
, Issue.2
, pp. 241-250
-
-
Xi, G.1
Hayes, E.2
Lewis, R.3
-
6
-
-
84925953926
-
Inhibition of Vav3 could reverse the drug resistance of gastric cancer cells by downregulating JNK signaling pathway
-
Tan B, Li Y, Zhao Q, et al. Inhibition of Vav3 could reverse the drug resistance of gastric cancer cells by downregulating JNK signaling pathway. Cancer Gene Ther. 2014;21(12):526–531.
-
(2014)
Cancer Gene Ther
, vol.21
, Issue.12
, pp. 526-531
-
-
Tan, B.1
Li, Y.2
Zhao, Q.3
-
7
-
-
84890127325
-
Improved therapeutic effect on malignant glioma with adenoviral suicide gene therapy combined with temozolomide
-
Stedt H, Samaranayake H, Pikkarainen J, et al. Improved therapeutic effect on malignant glioma with adenoviral suicide gene therapy combined with temozolomide. Gene Ther. 2013;20(12):1165–1171.
-
(2013)
Gene Ther
, vol.20
, Issue.12
, pp. 1165-1171
-
-
Stedt, H.1
Samaranayake, H.2
Pikkarainen, J.3
-
8
-
-
54749132655
-
Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo
-
Milacic V, Banerjee S, Landis-Piwowar KR. Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo. Cancer Res. 2008;68(18):7283–7292.
-
(2008)
Cancer Res
, vol.68
, Issue.18
, pp. 7283-7292
-
-
Milacic, V.1
Banerjee, S.2
Landis-Piwowar, K.R.3
-
9
-
-
27144468987
-
Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice
-
Aggarwal BB, Shishodia S, Takada Y, et al. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res. 2005;11(20):7490–7498.
-
(2005)
Clin Cancer Res
, vol.11
, Issue.20
, pp. 7490-7498
-
-
Aggarwal, B.B.1
Shishodia, S.2
Takada, Y.3
-
10
-
-
51649118928
-
Phase II trial of curcumin in patients with advanced pancreatic cancer
-
Dhillon N, Aggarwal BB, Newman RA, et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res. 2008;14(14):4491–4499.
-
(2008)
Clin Cancer Res
, vol.14
, Issue.14
, pp. 4491-4499
-
-
Dhillon, N.1
Aggarwal, B.B.2
Newman, R.A.3
-
11
-
-
34248573808
-
Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products
-
Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal BB. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res. 2007;67(8):3853–3861.
-
(2007)
Cancer Res
, vol.67
, Issue.8
, pp. 3853-3861
-
-
Kunnumakkara, A.B.1
Guha, S.2
Krishnan, S.3
Diagaradjane, P.4
Gelovani, J.5
Aggarwal, B.B.6
-
13
-
-
84860887008
-
The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma
-
Zanotto-Filho A, Braganhol E, Edelweiss MI, et al. The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma. J Nutr Biochem. 2012;23(6):591–601.
-
(2012)
J Nutr Biochem
, vol.23
, Issue.6
, pp. 591-601
-
-
Zanotto-Filho, A.1
Braganhol, E.2
Edelweiss, M.I.3
-
14
-
-
70350292588
-
Liposomes and nanoparticles: Nanosized vehicles for drug delivery in cancer
-
Malam Y, Loizidou M, Seifalian AM. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci. 2009;30(11):592–599.
-
(2009)
Trends Pharmacol Sci
, vol.30
, Issue.11
, pp. 592-599
-
-
Malam, Y.1
Loizidou, M.2
Seifalian, A.M.3
-
15
-
-
72449143090
-
Paclitaxel in cancer treatment: Perspectives and prospects of its delivery challenges
-
Singh S, Dash AK. Paclitaxel in cancer treatment: perspectives and prospects of its delivery challenges. Crit Rev Ther Drug Carrier Syst. 2009;26(4):333–372.
-
(2009)
Crit Rev Ther Drug Carrier Syst
, vol.26
, Issue.4
, pp. 333-372
-
-
Singh, S.1
Dash, A.K.2
-
16
-
-
77952585292
-
Targeted near-IR QDs-loaded micelles for cancer therapy and imaging
-
Nurunnabi M, Cho KJ, Choi JS, Huh KM, Lee YK. Targeted near-IR QDs-loaded micelles for cancer therapy and imaging. Biomaterials. 2010;31(20):5436–5444.
-
(2010)
Biomaterials
, vol.31
, Issue.20
, pp. 5436-5444
-
-
Nurunnabi, M.1
Cho, K.J.2
Choi, J.S.3
Huh, K.M.4
Lee, Y.K.5
-
18
-
-
77957677097
-
Cancer nanotechnology: Application of nanotechnology in cancer therapy
-
Misra R, Acharya S, Sahoo SK. Cancer nanotechnology: application of nanotechnology in cancer therapy. Drug Discov Today. 2010;15(19–20):842–850.
-
(2010)
Drug Discov Today
, vol.15
, Issue.19-20
, pp. 842-850
-
-
Misra, R.1
Acharya, S.2
Sahoo, S.K.3
-
19
-
-
84860766306
-
Efficient inhibition of colorectal peritoneal carcinomatosis by drug loaded micelles in thermosensitive hydrogel composites
-
Gong C, Wang C, Wang Y, et al. Efficient inhibition of colorectal peritoneal carcinomatosis by drug loaded micelles in thermosensitive hydrogel composites. Nanoscale. 2012;4(10):3095–3104.
-
(2012)
Nanoscale
, vol.4
, Issue.10
, pp. 3095-3104
-
-
Gong, C.1
Wang, C.2
Wang, Y.3
-
20
-
-
79953054576
-
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
-
Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2011;63(3):136–151.
-
(2011)
Adv Drug Deliv Rev
, vol.63
, Issue.3
, pp. 136-151
-
-
Fang, J.1
Nakamura, H.2
Maeda, H.3
-
21
-
-
77952575335
-
Tumor-selective delivery of macromolecular drugs via the EPR effect: Background and future prospects
-
Maeda H. Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. Bioconjug Chem. 2010;21(5):797–802.
-
(2010)
Bioconjug Chem
, vol.21
, Issue.5
, pp. 797-802
-
-
Maeda, H.1
-
22
-
-
84875793390
-
Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer
-
Gao X, Wang B, Wei X, et al. Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer. Nanoscale. 2012;4(22):7021–7030.
-
(2012)
Nanoscale
, vol.4
, Issue.22
, pp. 7021-7030
-
-
Gao, X.1
Wang, B.2
Wei, X.3
-
23
-
-
84885441283
-
Improving the anti-colon cancer activity of curcumin with biodegradable nano-micelles
-
Gao X, Zheng FJ, Guo G, et al. Improving the anti-colon cancer activity of curcumin with biodegradable nano-micelles. J Mater Chem B. 2013;1:5778–5790.
-
(2013)
J Mater Chem B
, vol.1
, pp. 5778-5790
-
-
Gao, X.1
Zheng, F.J.2
Guo, G.3
-
24
-
-
84916898421
-
ROS-responsive microspheres for on demand antioxidant therapy in a model of diabetic peripheral arterial disease
-
Poole KM, Nelson CE, Joshi RV, et al. ROS-responsive microspheres for on demand antioxidant therapy in a model of diabetic peripheral arterial disease. Biomaterials. 2015;41:166–175.
-
(2015)
Biomaterials
, vol.41
, pp. 166-175
-
-
Poole, K.M.1
Nelson, C.E.2
Joshi, R.V.3
-
25
-
-
84899147486
-
The amelioration of phagocytic ability in microglial cells by curcumin through the inhibition of EMF-induced pro-inflammatory responses
-
He GL, Liu Y, Li M, et al. The amelioration of phagocytic ability in microglial cells by curcumin through the inhibition of EMF-induced pro-inflammatory responses. J Neuroinflammation. 2014;11:49.
-
(2014)
J Neuroinflammation
, vol.11
, pp. 49
-
-
He, G.L.1
Liu, Y.2
Li, M.3
-
26
-
-
84904288914
-
SAR studies on curcumin’s pro-inflammatory targets: Discovery of prenylated pyrazolocurcuminoids as potent and selective novel inhibitors of 5-lipoxygenase
-
Koeberle A, Muñoz E, Appendino GB, et al. SAR studies on curcumin’s pro-inflammatory targets: discovery of prenylated pyrazolocurcuminoids as potent and selective novel inhibitors of 5-lipoxygenase. J Med Chem. 2014;57(13):5638–5648.
-
(2014)
J Med Chem
, vol.57
, Issue.13
, pp. 5638-5648
-
-
Koeberle, A.1
Muñoz, E.2
Appendino, G.B.3
-
27
-
-
84903538176
-
Lipid-polymer nanoparticles encapsulating curcumin for modulating the vascular deposition of breast cancer cells
-
Palange AL, Di Mascolo D, Carallo C, Gnasso A, Decuzzi P. Lipid-polymer nanoparticles encapsulating curcumin for modulating the vascular deposition of breast cancer cells. Nanomedicine. 2014;10(5):991–1002.
-
(2014)
Nanomedicine
, vol.10
, Issue.5
, pp. 991-1002
-
-
Palange, A.L.1
di Mascolo, D.2
Carallo, C.3
Gnasso, A.4
Decuzzi, P.5
-
28
-
-
84879605060
-
EGRF conjugated PEGylated nanographene oxide for targeted chemotherapy and photothermal therapy
-
Yang HW, Lu YJ, Lin KJ, et al. EGRF conjugated PEGylated nanographene oxide for targeted chemotherapy and photothermal therapy. Biomaterials. 2013;34(29):7204–7214.
-
(2013)
Biomaterials
, vol.34
, Issue.29
, pp. 7204-7214
-
-
Yang, H.W.1
Lu, Y.J.2
Lin, K.J.3
-
29
-
-
33644838070
-
Curcuminoids purified from turmeric powder modulate the function of human multidrug resistance protein 1 (ABCC1)
-
Chearwae W, Wu CP, Chu HY, Lee TR, Ambudkar SV, Limtrakul P. Curcuminoids purified from turmeric powder modulate the function of human multidrug resistance protein 1 (ABCC1). Cancer Chemother Pharmacol. 2006;57(3):376–388.
-
(2006)
Cancer Chemother Pharmacol
, vol.57
, Issue.3
, pp. 376-388
-
-
Chearwae, W.1
Wu, C.P.2
Chu, H.Y.3
Lee, T.R.4
Ambudkar, S.V.5
Limtrakul, P.6
-
30
-
-
84927940418
-
Anti-inflammatory activity of curcumin-loaded solid lipid nanoparticles in IL-1β transgenic mice subjected to the lipopolysaccharide-induced sepsis
-
Wang J, Wang H, Zhu R, Liu Q, Fei J, Wang S. Anti-inflammatory activity of curcumin-loaded solid lipid nanoparticles in IL-1β transgenic mice subjected to the lipopolysaccharide-induced sepsis. Biomaterials. 2015;53:475–483.
-
(2015)
Biomaterials
, vol.53
, pp. 475-483
-
-
Wang, J.1
Wang, H.2
Zhu, R.3
Liu, Q.4
Fei, J.5
Wang, S.6
-
31
-
-
80052386569
-
Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles
-
Wang H, Zhao Y, Wu Y, et al. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Biomaterials. 2011;32(32):8281–8290.
-
(2011)
Biomaterials
, vol.32
, Issue.32
, pp. 8281-8290
-
-
Wang, H.1
Zhao, Y.2
Wu, Y.3
-
32
-
-
84921520715
-
Methoxy poly(Ethylene glycol)-poly(lactide) nanoparticles encapsulating quercetin act as an effective anticancer agent by inducing apoptosis in breast cancer
-
Sharma G, Park J, Sharma AR, et al. Methoxy poly(ethylene glycol)-poly(lactide) nanoparticles encapsulating quercetin act as an effective anticancer agent by inducing apoptosis in breast cancer. Pharm Res. 2015;32(2):723–735.
-
(2015)
Pharm Res
, vol.32
, Issue.2
, pp. 723-735
-
-
Sharma, G.1
Park, J.2
Sharma, A.R.3
-
33
-
-
84892446429
-
Toward immunosuppressive effects on liver transplantation in rat model: Tacrolimus loaded poly(ethylene glycol)-poly(d,l-lactide) nanoparticle with longer survival time
-
Xu W, Ling P, Zhang T. Toward immunosuppressive effects on liver transplantation in rat model: tacrolimus loaded poly(ethylene glycol)-poly(d,l-lactide) nanoparticle with longer survival time. Int J Pharm. 2014;460(1–2):173–180.
-
(2014)
Int J Pharm
, vol.460
, Issue.1-2
, pp. 173-180
-
-
Xu, W.1
Ling, P.2
Zhang, T.3
-
34
-
-
77955873538
-
Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells
-
Yallapu MM, Gupta BK, Jaggi M, Chauhan SC. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J Colloid Interface Sci. 2010;351:19–29.
-
(2010)
J Colloid Interface Sci
, vol.351
, pp. 19-29
-
-
Yallapu, M.M.1
Gupta, B.K.2
Jaggi, M.3
Chauhan, S.C.4
-
35
-
-
79952303941
-
Preparation of tacrolimus loaded micelles based on poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone)
-
Wang Y, Wang C, Fu S, et al. Preparation of tacrolimus loaded micelles based on poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone). Int J Pharm. 2011;407(1–2):184–189.
-
(2011)
Int J Pharm
, vol.407
, Issue.1-2
, pp. 184-189
-
-
Wang, Y.1
Wang, C.2
Fu, S.3
-
36
-
-
84864565220
-
Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats
-
Najeh MK, do Nascimento TC, Casa DM, et al. Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats. Colloids Surf B Biointerfaces. 2013;101:353–360.
-
(2013)
Colloids Surf B Biointerfaces
, vol.101
, pp. 353-360
-
-
Najeh, M.K.1
Do Nascimento, T.C.2
Casa, D.M.3
-
37
-
-
84973900909
-
Photoprotective efficiency of PLGA-curcumin nanoparticles versus curcumin through the involvement of ERK/AKT pathway under ambient UV-R exposure in HaCaT cell line
-
Deepti C, Lipika R, Ashish D, et al. Photoprotective efficiency of PLGA-curcumin nanoparticles versus curcumin through the involvement of ERK/AKT pathway under ambient UV-R exposure in HaCaT cell line. Biomaterials. 2016;84:25–41.
-
(2016)
Biomaterials
, vol.84
, pp. 25-41
-
-
Deepti, C.1
Lipika, R.2
Ashish, D.3
-
38
-
-
84893694889
-
Curcumin nanoformulations: A review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment
-
Naksuriya O, Okonogi S, Schiffelers RM, Hennink WE. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterials. 2014;35(10):3365–3383.
-
(2014)
Biomaterials
, vol.35
, Issue.10
, pp. 3365-3383
-
-
Naksuriya, O.1
Okonogi, S.2
Schiffelers, R.M.3
Hennink, W.E.4
-
39
-
-
84904738421
-
Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer
-
Yallapu MM, Khan S, Maher DM, et al. Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer. Biomaterials. 2014;35(30):8635–8648.
-
(2014)
Biomaterials
, vol.35
, Issue.30
, pp. 8635-8648
-
-
Yallapu, M.M.1
Khan, S.2
Maher, D.M.3
-
40
-
-
84880540766
-
Curcumin-derivative nanomicelles for the treatment of triple negative breast cancer
-
Taurin S, Nehoff H, Diong J, Larsen L, Rosengren RJ, Greish K. Curcumin-derivative nanomicelles for the treatment of triple negative breast cancer. J Drug Target. 2013;21(7):675–683.
-
(2013)
J Drug Target
, vol.21
, Issue.7
, pp. 675-683
-
-
Taurin, S.1
Nehoff, H.2
Diong, J.3
Larsen, L.4
Rosengren, R.J.5
Greish, K.6
-
41
-
-
42049110950
-
Application of nanotechnology in cancer therapy and imaging
-
Wang X, Yang L, Chen ZG, Shin DM. Application of nanotechnology in cancer therapy and imaging. CA Cancer J Clin. 2008;58(2):97–110.
-
(2008)
CA Cancer J Clin
, vol.58
, Issue.2
, pp. 97-110
-
-
Wang, X.1
Yang, L.2
Chen, Z.G.3
Shin, D.M.4
-
42
-
-
77956398535
-
Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer
-
Gao Y, Li Z, Sun M, et al. Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer. Drug Dev Ind Pharm. 2010;36(10):1225–1234.
-
(2010)
Drug Dev Ind Pharm
, vol.36
, Issue.10
, pp. 1225-1234
-
-
Gao, Y.1
Li, Z.2
Sun, M.3
-
43
-
-
84922551542
-
Inulin-D-alpha-tocopherol succinate (INVITE) nanomicelles as a platform for effective intravenous administration of curcumin
-
Tripodo G, Pasut G, Trapani A, et al. Inulin-D-alpha-tocopherol succinate (INVITE) nanomicelles as a platform for effective intravenous administration of curcumin. Biomacromolecules. 2015;16(2):550–557.
-
(2015)
Biomacromolecules
, vol.16
, Issue.2
, pp. 550-557
-
-
Tripodo, G.1
Pasut, G.2
Trapani, A.3
-
44
-
-
84880348522
-
Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability
-
Sun J, Bi C, Chan HM, Sun S, Zhang Q, Zheng Y. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability. Colloids Surf B Biointerfaces. 2013;111:367–375.
-
(2013)
Colloids Surf B Biointerfaces
, vol.111
, pp. 367-375
-
-
Sun, J.1
Bi, C.2
Chan, H.M.3
Sun, S.4
Zhang, Q.5
Zheng, Y.6
-
45
-
-
84877251818
-
Polymeric curcumin nanoparticle pharmacokinetics and metabolism in bile duct cannulated rats
-
Zou P, Helson L, Maitra A, Stern ST, McNeil SE. Polymeric curcumin nanoparticle pharmacokinetics and metabolism in bile duct cannulated rats. Mol Pharm. 2013;10(5):1977–1987.
-
(2013)
Mol Pharm
, vol.10
, Issue.5
, pp. 1977-1987
-
-
Zou, P.1
Helson, L.2
Maitra, A.3
Stern, S.T.4
McNeil, S.E.5
-
46
-
-
77953958625
-
The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation
-
Mohanty C, Sahoo SK. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials. 2010;31(25):6597–6611.
-
(2010)
Biomaterials
, vol.31
, Issue.25
, pp. 6597-6611
-
-
Mohanty, C.1
Sahoo, S.K.2
-
47
-
-
84920136726
-
Mesenchymal stromal cells loading curcumin-INVITE-micelles: A drug delivery system for neurodegenerative diseases
-
Tripodo G, Chlapanidas T, Perteghella S, et al. Mesenchymal stromal cells loading curcumin-INVITE-micelles: a drug delivery system for neurodegenerative diseases. Colloids Surf B Biointerfaces. 2015;125(0):300–308.
-
(2015)
Colloids Surf B Biointerfaces
, vol.125
, pp. 300-308
-
-
Tripodo, G.1
Chlapanidas, T.2
Perteghella, S.3
-
48
-
-
84924308384
-
Immunophenotypic characterization of human glioblastoma stem cells: Correlation with clinical outcome
-
Miconi G, Palumbo P, Dehcordi SR, et al. Immunophenotypic characterization of human glioblastoma stem cells: correlation with clinical outcome. J Cell Biochem. 2015;116(5):864–876.
-
(2015)
J Cell Biochem
, vol.116
, Issue.5
, pp. 864-876
-
-
Miconi, G.1
Palumbo, P.2
Dehcordi, S.R.3
-
49
-
-
84951011334
-
Ki67/SATB1 ratio is an independent prognostic factor of overall survival in patients with early hormone receptor-positive invasive ductal breast carcinoma
-
Laurinavicius A, Green AR, Laurinaviciene A, et al. Ki67/SATB1 ratio is an independent prognostic factor of overall survival in patients with early hormone receptor-positive invasive ductal breast carcinoma. Oncotarget. 2015;6(38):41134–41145.
-
(2015)
Oncotarget
, vol.6
, Issue.38
, pp. 41134-41145
-
-
Laurinavicius, A.1
Green, A.R.2
Laurinaviciene, A.3
|